BrainStorm Announces Exceptional Preclinical Results of NurOwn™ in Mouse Autism Model|
BrainStorm Cell Therapeutics Inc. announced positive results from preclinical studies of NurOwn™ in the BTBR mouse model of autism. NurOwn™ cells are mesenchymal stem cells that have been induced, under BrainStorm’s proprietary methods, to secrete a variety of neurotrophic factors. [BrainStorm Cell Therapeutics Inc.] Press Release
BioTime Announces Issuance of 14 New Patents in the Fields of Regenerative Medicine, Stem Cell Technology, and Cancer Therapy
BioTime, Inc. announced the issuance of 14 new patents covering a wide range of the core technologies of BioTime and its subsidiaries Asterias Biotherapeutics, Inc., OrthoCyte Corporation, ES Cell International Pte Ltd, OncoCyte Corporation, and ReCyte Therapeutics, Inc. [BioTime, Inc.] Press Release
From our sponsor: Learn about assays for cord blood. Download the free technical bulletin.